Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT05067634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Lead sponsor
SK Life Science, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 10, 2022
Completion date
November 30, 2026
Enrollment
140 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

partial epilepsy